These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

899 related items for PubMed ID: 10977011

  • 1. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [Abstract] [Full Text] [Related]

  • 2. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS, Dominguez-Lopez ME, Gonzalez-Molero I, Machado A, Martin V, Cardona I, de-la-Higuera M, Tapia MJ, Soriguer F, Anarte MT, Rojo-Martínez G.
    Med Clin (Barc); 2016 Mar 18; 146(6):239-46. PubMed ID: 26656958
    [Abstract] [Full Text] [Related]

  • 3. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
    Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.
    Diabetes Care; 2009 Jul 18; 32(7):1170-6. PubMed ID: 19389820
    [Abstract] [Full Text] [Related]

  • 4. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L, Dicembrini I, Mannucci E.
    Acta Diabetol; 2019 Sep 18; 56(9):973-980. PubMed ID: 30945047
    [Abstract] [Full Text] [Related]

  • 5. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
    Melki V, Renard E, Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H, Bringer J, Belicar P, Jeandidier N, Meyer L, Blin P, Augendre-Ferrante B, Tauber JP.
    Diabetes Care; 1998 Jun 18; 21(6):977-82. PubMed ID: 9614617
    [Abstract] [Full Text] [Related]

  • 6. Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.
    Bode BW, Steed RD, Schleusener DS, Strange P.
    Endocr Pract; 2005 Jun 18; 11(3):157-64. PubMed ID: 16239201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
    Renner R, Pfützner A, Trautmann M, Harzer O, Sauter K, Landgraf R.
    Diabetes Care; 1999 May 18; 22(5):784-8. PubMed ID: 10332682
    [Abstract] [Full Text] [Related]

  • 10. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study.
    Lepore G, Dodesini AR, Nosari I, Trevisan R.
    Diabetes Nutr Metab; 2004 Apr 18; 17(2):84-9. PubMed ID: 15244099
    [Abstract] [Full Text] [Related]

  • 11. Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes.
    Gong Y, Wei T, Liu Y, Wang J, Yan J, Yang D, Luo S, Weng J, Zheng X.
    J Diabetes; 2024 May 18; 16(5):e13558. PubMed ID: 38664886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2009 May 18; 9(20):1-58. PubMed ID: 23074525
    [Abstract] [Full Text] [Related]

  • 15. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G, High Mix Study Group.
    Clin Ther; 2004 Apr 18; 26(4):502-10. PubMed ID: 15189747
    [Abstract] [Full Text] [Related]

  • 16. A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: a prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusion.
    Kamoi K, Miyakoshi M, Maruyama R.
    Diabetes Res Clin Pract; 2004 Apr 18; 64(1):19-25. PubMed ID: 15036823
    [Abstract] [Full Text] [Related]

  • 17. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
    Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW, Insulin Aspart CSII/MDI Comparison Study Group.
    Diabetes Care; 2005 Mar 18; 28(3):533-8. PubMed ID: 15735183
    [Abstract] [Full Text] [Related]

  • 18. Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study.
    Johansson UB, Adamson UC, Lins PE, Wredling RA.
    Diabetes Metab; 2000 May 18; 26(3):192-6. PubMed ID: 10880892
    [Abstract] [Full Text] [Related]

  • 19. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J, McKay A, Ridyard C, Thornborough K, Bedson E, Peak M, Didi M, Annan F, Gregory JW, Hughes D, Gamble C.
    Health Technol Assess; 2018 Aug 18; 22(42):1-112. PubMed ID: 30109847
    [Abstract] [Full Text] [Related]

  • 20. Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.
    Kaiserman K, Rodriguez H, Stephenson A, Wolka L, Fahrbach JL.
    Endocr Pract; 2012 Aug 18; 18(3):418-24. PubMed ID: 22297055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.